Pain BridgeNeuromodulation

rTMS (Repetitive Transcranial Magnetic Stimulation) calming the signal

Non-invasive neuromodulation using magnetic pulses through the scalp, delivered as a structured course of outpatient sessions.

What it is and how it works

Non-invasive neuromodulation using magnetic pulses delivered through the scalp to targeted brain regions, without anaesthesia or incision. Repeated pulses are thought to modulate cortical excitability in the stimulated region and its connected networks, and the therapy is given as a structured course of repeated outpatient sessions rather than a single treatment.

  • Assessed first. We look at the whole pain pattern before recommending this.

  • Individualised. Dose, pace and progression are matched to you.

  • Reviewed. Progress is checked at follow-ups and the plan changes if it isn't working.

Two sides. A clearer picture.

In the clinic

How it's done

Typically administered as daily outpatient sessions, five days a week, over roughly 4–6 weeks (commonly 20–30 sessions in total), with each session lasting approximately 30–40 minutes and delivered under trained clinical supervision; “accelerated” protocols delivering multiple sessions per day over a shorter span also exist. No anaesthesia or sedation is required, and patients typically resume normal activity immediately afterward.

Our approach

Why Pain Bridge

Pain Bridge positions neuromodulation like rTMS within an evidence-bounded, individualized model of care — offered where clinically indicated after structured assessment, alongside rather than instead of established therapy, consistent with the clinic's broader commitment to not promising a guaranteed outcome.

Questions, answered

Does rTMS hurt?

Most people tolerate it well — some experience scalp discomfort, a tapping sensation, or mild headache during or shortly after a session, which tends to ease as treatment continues and is generally manageable with over-the-counter pain relief if needed.

Who shouldn't have rTMS?

It's generally avoided in people with certain metal implants or devices near the head (such as cochlear implants, aneurysm clips, or implanted stimulators) and used with caution in those with an active or recent seizure disorder, given a small associated seizure risk; a screening assessment before treatment checks for these factors.

References

  1. Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry, 2017. Source
  2. Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clinical Neurophysiology, 2020. Source
  3. Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet, 2018. Source
  4. Smith JR, DiSalvo M, Green A, et al. Treatment Response of Transcranial Magnetic Stimulation in Intellectually Capable Youth and Young Adults with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Neuropsychology Review, 2023. Source

Pain for months? Let's look properly.

  1. 1Book a visitChoose a time at our Delhi clinic.
  2. 2Full assessmentWe look at your whole pain pattern, not a single scan or test result.
  3. 3Your planYou leave with a plan, the reasoning behind it, and dates to review it.